Irinotecan is widely used in clinical practice, in particular to treat colon cancer patients [38], and we next asked whether expression of HMGA2 affected chemosensitivity to irinotecan in patient-derived xenograft (PDX) models of colorectal cancers. The gene discussed is HMGA2; the disease is colorectal cancer.